Acam2000 Injection, Powder, Lyophilized, For Solution
Product Images NDC 71665-430

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Acam2000 (NDC 71665-430). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Emergent Product Development Gaithersburg Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Acam Vial Label.jpg (Acam Vial Label)

Acam Vial Label.jpg (Acam Vial Label)
This is a description of a smallpox vaccine named ACAM2000® . It is only for use in the Strategic National Stockpile and should be stored between 2-8°C (36-46°F). The vaccine must be used within thirty days of reconstitution and should only be administered percutaneously with a bifurcated needle. It should not be given intravenously. The vaccine has a fill volume of 0.3 mL/100 doses and a potency of 1-5x10^8 PFU/mL. The manufacturer of this vaccine is Emergent Product Development in Gaithersburg, MD 20879 USA.*
FDA Label Image

M:\ra\ectd\spl\labels\acam\april 2018\medguide Image 1 Expected Response.jpg (Image 01)

FDA Label Image

Medguide Image 1 Infected Arm.jpg (Image 02)

FDA Label Image

Medguide Image 2 Infected Eye.jpg (Image 03)

FDA Label Image

Acam Carton Label.jpg (Image 04)

Acam Carton Label.jpg (Image 04)
This is a description of the Smallpox (Vaccinia) Vaccine, Live called ACAM2000. It is administered through percutaneous inoculation with Bifurcated Needle only and contains trace amounts of antibiotics (Neomycin and Polymyxin B). The vaccine has an approximate dose of 2.5 uL and a potency of 1-5x108 PFU/mL. The expiration date is indicated, and the vaccine should be stored at -25 to -15°C (-13 to 5°F) until distributed for use. After distribution, it may be stored at 2-8°C (36-46°F) for up to 18 months and should be used within 30 days of reconstitution. The manufacturer is Emergent Product Development Gaithersburg Inc. The package insert should be referred to for full prescribing and product information.*
FDA Label Image

Images Of The Expected Cutaneous Reaction From Day 3 To Day 14 After Revaccination Showing Modified (reduced) Reaction Compared To Primary Vaccination. (Rad643fe.tmp 00.jpg)

FDA Label Image

Images Of The Expected Cutaneous Reaction After Primary Vaccination Showing Progression From A Vesicle (day 5) To A Pustule (days 8-10) To A Scab (day 14). (Rad643fe.tmp 01.jpg)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.